Human NSCLC cell lines HCC827 (EGFR exon 19 deletion [delE746-A750]) and erlotinib-resistant HCC827ER cells harboring MET gene amplification were used in this study. The gene discussed is MET; the disease is non-small cell lung carcinoma.